Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
01 1Transo-Pharm Handels GmbH
02 1LGM Pharma
03 1Transo-Pharm USA LLC
04 1DKSH
05 1Jai Radhe Sales
06 1Adorkem Technology S.p.A.
07 1Aspen Biopharma Labs
08 2Boryung Pharmaceutical Co., Ltd
09 1Concord Biotech
10 1DZD Heze Pharmaceutical Co Ltd
11 1Gemini PharmChem
12 1Guangzhou Topwork Chemical
13 1Hangzhou Longshine Bio-Tech
14 1Intas Pharmaceuticals
15 1Jiwan Pharmaceutical Technology Co., Ltd
16 2Meiji Seika Pharma
17 1MicroBiopharm Japan
18 1Olon S.p.A
19 2Pfizer Inc
20 1RPG Life Sciences Ltd.
21 1Sakar Healthcare
22 1Sicor Spa
23 1Sterling Biotech
24 1Sun-shine Chem
25 1Synbias Pharma Limited Liability Company
26 1Tecoland Corporation
27 1Teva API
28 1Teva Pharmaceutical Industries
29 2Zhejiang Hisun Pharmaceutical
30 1Zhejiang Huida Biotech
01 8China
02 2Germany
03 7India
04 2Israel
05 3Italy
06 3Japan
07 2South Korea
08 1Switzerland
09 5U.S.A
10 1Ukraine
01 11Active
02 3Inactive
03 20Blank
01 1Expired
02 12Valid
03 1Withdrawn by Holder
04 20Blank
01 1218MF10960
02 1223MF10126
03 1226MF10124
04 1302MF10073
05 1303MF10121
06 1305MF10028
07 28Blank
01 1WC-0292
02 2WC-0357
03 31Blank
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
Certificate Number : R1-CEP 2004-059 - Rev 03
Issue Date : 2023-03-06
Type : Chemical
Substance Number : 714
Status : Valid
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-10-18
Pay. Date : 2015-12-28
DMF Number : 13209
Submission : 1998-04-30
Status : Active
Type : II
Certificate Number : R1-CEP 2003-151 - Rev 03
Issue Date : 2020-04-02
Type : Chemical
Substance Number : 714
Status : Valid
Registration Number : 302MF10073
Registrant's Address : 2-4-16 Kyobashi, Chuo-ku, Tokyo
Initial Date of Registration : 2020-07-01
Latest Date of Registration : --
NDC Package Code : 12543-3209
Start Marketing Date : 2010-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10g/10g)
Marketing Category : BULK INGREDIENT
Registrant Name : Boxter Co., Ltd.
Registration Date : 2021-02-17
Registration Number : 20210217-210-J-674
Manufacturer Name : Meiji Seika Pharma Co., Ltd. Kitakami Plant
Manufacturer Address : 3-3, Kitakogyodanchi Kitakami-shi, Iwate-ken 024-0193, Japan
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-03-07
Pay. Date : 2012-12-18
DMF Number : 13773
Submission : 1998-09-01
Status : Active
Type : II
Certificate Number : CEP 2013-262 - Rev 02
Issue Date : 2024-10-09
Type : Chemical
Substance Number : 714
Status : Valid
Registration Number : 226MF10124
Registrant's Address : 46 Waisha Road, Jiaojiang District, Taizhou City, Zhejiang Province, P. R. China 318000
Initial Date of Registration : 2014-07-01
Latest Date of Registration : --
NDC Package Code : 58623-0029
Start Marketing Date : 1996-09-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-08-27
Pay. Date : 2024-07-18
DMF Number : 31153
Submission : 2016-11-11
Status : Active
Type : II
Certificate Number : R1-CEP 2016-254 - Rev 00
Issue Date : 2022-11-22
Type : Chemical
Substance Number : 714
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24128
Submission : 2010-08-31
Status : Inactive
Type : II
Date of Issue : 2016-02-23
Valid Till : 2019-02-23
Written Confirmation Number : WC-0357
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16270
Submission : 2002-11-21
Status : Inactive
Type : II
We have 30 companies offering Doxorubicin Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?